SRX Global is trading at $1.42, down 5.03%, amid broader market and technology-sector pressure. - The technology sector is down 2.05%, and the Nasdaq is down 1.43% in the supplied market context. - Geopolitical tensions, rising oil prices and elevated Treasury yields are weighing on equities, particularly growth-oriented technology stocks. - No verified company-specific catalyst or trading-volume data is available. SRX Global announced a CERo Therapeutics acquisition agreement on October 7; closing conditions remain outstanding, and the announcement does not explain the decline.